info

Wednesday, 19 June 2019

Skin-On-Chips for Drug Discovery of Chronic Wounds

                                         https://www.austinpublishinggroup.com/tissue-engineering/




Diabeticfoot ulcers, venous leg ulcers, and pressure ulcers contribute to majority of chronic wounds. The importance of improved wound healing measure is especially well demonstrated by the healing problems in diabetes. It is estimated that about 30% of all the costs for diabetes relates to wound care in USA. In addition, 2.4-4.5 million people have been reported to have chronic lower extremity ulcers in USA only. Pressure ulcers and leg ulcers, including venous ulcers, cost as high as $8 billion annually in USA, and are a significant cause of morbidity in aged population. Although a slow wound repair is a self-limiting process and not a pathogenesis in itself, severe chronic wounds can also lead to chronic inflammatory diseases, fibrosis, and cancer, comprising stifling economic health care burdens.

Woundhealing in clinical settings relies primarily on enabling the natural course of epidermal tissue regeneration. In many cases, the involved processes and the progress of regeneration may be insufficient to save severely injured patients. Especially difficult are various types of chronic wounds, with diabetic wounds being the most severe type. Current conventional treatment of chronic wound comprises mainly approaches with various types of dressings, bandages, and antibiotics. Several skin substitutes have reached the market place for second-line therapy of chronic ulcers, but they have not had the impact that was predicted. In severe cases where the wounds do not heal, amputation is the only treatment option that is available.


No comments:

Post a Comment

An Evaluation of the Role of fMRI in Patients with Lower Urinary Tract Dysfunction

                                                 https://www.austinpublishinggroup.com/urology/ Patientswith Lower Urinary Tr...